이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

QHSLab 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Troy Grogan

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	9.2yrs
CEO 소유권	32.8%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.4yrs

최근 관리 업데이트

Recent updates

CEO

Troy Grogan (47 yo)

9.2yrs

테뉴어

Mr. Troy James Grogan has been Chief Executive Officer and Chairman of the Board at QHSLab, Inc. (formerly known as USA Equities Corp.) since June 2016 and also serves as its President. Mr. Grogan has a ba...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Troy Grogan	CEO, CFO	9.2yrs	데이터 없음	32.82% $ 1.0m
Reza Yavari	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Frank Lichtenberger	Member of Medical & Scientific Advisory Board	3.4yrs	데이터 없음	데이터 없음
Bjorn Herman	Member of Medical & Scientific Advisory Board	3.4yrs	데이터 없음	데이터 없음
Juan Escobar	Member of Medical & Scientific Advisory Board	3.4yrs	데이터 없음	데이터 없음
Fredric Pullen	Member of Medical & Scientific Advisory Board	3.4yrs	데이터 없음	데이터 없음
Alex Mirakian	Member of Scientific & Medical Board of Advisors	no data	데이터 없음	데이터 없음
Syed A. Rizvi	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Marcos Sanchez-Gonzalez	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음

3.4yrs

평균 재임 기간

경험이 풍부한 이사회: USAQ 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.

QHSLab 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

USA Equities Corp. Appoints Mike Mangus to Its Advisory and Physician Network Development Team

USA Equities Corp. Announces Management Changes

Recent updates

QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force

Qhslab, Inc. Launches A “Long Covid” Digital Health Tool for Primary Care Physicians

USA Equities Corp. announced delayed annual 10-K filing

USA Equities Corp. Introduces AllergiQT™– Quick Test, Further Expanding Market Presence

USA Equities Corp. (OTCPK:USAQ) acquired the method patent, trademark and website associated with AllergiEnd®’s diagnostic and allergen immunotherapy product portfolio from MedScience Research Group, Inc.

USA Equities Corp. Provides Revenue Guidance for the Third Quarter of 2021

USA Equities Corp. (OTCPK : USAQ) entered into an asset purchase agreement to acquire The AllergiEnd® diagnostic and allergen immunotherapy system from MedScience Research Group, Inc.

USA Equities Corp. Appoints Mike Mangus to Its Advisory and Physician Network Development Team

USA Equities Corp. Announces Management Changes

USA Equities Corp Enters into Exclusive Distribution Agreement with MedScience Research Group

USA Equities Corp. announced that it expects to receive $0.5 million in funding

CEO

테뉴어

이사회 구성원

평균 재임 기간